These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 25672710)

  • 1. [Pathogenesis of cognitive impairment in multiple sclerosis].
    Nakahara J
    Rinsho Shinkeigaku; 2014; 54(12):1063-5. PubMed ID: 25672710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Correlation between demyelinating lesions and executive function decline in a sample of Mexican patients with multiple sclerosis].
    Aldrete Cortez VR; Duriez-Sotelo E; Carrillo-Mora P; Pérez-Zuno JA
    Neurologia; 2013 Sep; 28(7):394-9. PubMed ID: 23260448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cortical demyelination in multiple sclerosis: a substrate for cognitive deficits?
    Kutzelnigg A; Lassmann H
    J Neurol Sci; 2006 Jun; 245(1-2):123-6. PubMed ID: 16650874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thalamic atrophy and cognition in multiple sclerosis.
    Houtchens MK; Benedict RH; Killiany R; Sharma J; Jaisani Z; Singh B; Weinstock-Guttman B; Guttmann CR; Bakshi R
    Neurology; 2007 Sep; 69(12):1213-23. PubMed ID: 17875909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRI markers of destructive pathology in multiple sclerosis-related cognitive dysfunction.
    Rovaris M; Comi G; Filippi M
    J Neurol Sci; 2006 Jun; 245(1-2):111-6. PubMed ID: 16626748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cognitive impairment in multiple sclerosis].
    Karlińska I; Selmaj K
    Neurol Neurochir Pol; 2005; 39(2):125-33. PubMed ID: 15871058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive impairment in multiple sclerosis.
    Jongen PJ; Ter Horst AT; Brands AM
    Minerva Med; 2012 Apr; 103(2):73-96. PubMed ID: 22513513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain atrophy and cognitive impairment in multiple sclerosis: a review.
    Lanz M; Hahn HK; Hildebrandt H
    J Neurol; 2007 May; 254 Suppl 2():II43-8. PubMed ID: 17503128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of cognitive impairment and thalamic atrophy in MS: for men only?
    Fisher E; Benedict RH
    Neurology; 2012 Oct; 79(17):1748-9. PubMed ID: 23019258
    [No Abstract]   [Full Text] [Related]  

  • 10. Exploration of the relationships between regional grey matter atrophy and cognition in multiple sclerosis.
    Nocentini U; Bozzali M; Spanò B; Cercignani M; Serra L; Basile B; Mannu R; Caltagirone C; De Luca J
    Brain Imaging Behav; 2014 Sep; 8(3):378-86. PubMed ID: 22584774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cognitive impairment in multiple sclerosis].
    Ochi H
    Brain Nerve; 2014 Oct; 66(10):1201-9. PubMed ID: 25296874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain volumetry counterparts of cognitive impairment in patients with multiple sclerosis.
    Sastre-Garriga J; Arévalo MJ; Renom M; Alonso J; González I; Galán I; Montalban X; Rovira A
    J Neurol Sci; 2009 Jul; 282(1-2):120-4. PubMed ID: 19157420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thalamic atrophy and cognitive impairment in clinically isolated syndrome and multiple sclerosis.
    Štecková T; Hluštík P; Sládková V; Odstrčil F; Mareš J; Kaňovský P
    J Neurol Sci; 2014 Jul; 342(1-2):62-8. PubMed ID: 24819917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MRI and cognition in multiple sclerosis.
    Filippi M; Rocca MA
    Neurol Sci; 2010 Nov; 31(Suppl 2):S231-4. PubMed ID: 20635114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive impairment in relation to MRI metrics in patients with clinically isolated syndrome.
    Khalil M; Enzinger C; Langkammer C; Petrovic K; Loitfelder M; Tscherner M; Jehna M; Bachmaier G; Wallner-Blazek M; Ropele S; Schmidt R; Fuchs S; Fazekas F
    Mult Scler; 2011 Feb; 17(2):173-80. PubMed ID: 20956399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of atrophy and white matter mean diffusivity within the thalamus of multiple sclerosis patients.
    Benedict RH; Hulst HE; Bergsland N; Schoonheim MM; Dwyer MG; Weinstock-Guttman B; Geurts JJ; Zivadinov R
    Mult Scler; 2013 Oct; 19(11):1478-84. PubMed ID: 23459570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Brain atrophy and cognitive disorder in multiple sclerosis].
    Pál E; Kosztolányi P; Perlaky P
    Orv Hetil; 2002 Dec; 143(48):2681-5. PubMed ID: 12501577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cortical pathology and cognitive impairment in multiple sclerosis.
    Calabrese M; Rinaldi F; Grossi P; Gallo P
    Expert Rev Neurother; 2011 Mar; 11(3):425-32. PubMed ID: 21375447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive reserve moderates the negative effect of brain atrophy on cognitive efficiency in multiple sclerosis.
    Sumowski JF; Chiaravalloti N; Wylie G; Deluca J
    J Int Neuropsychol Soc; 2009 Jul; 15(4):606-12. PubMed ID: 19573279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cortical lesions and brain atrophy in MS.
    Kutzelnigg A; Lassmann H
    J Neurol Sci; 2005 Jun; 233(1-2):55-9. PubMed ID: 15893328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.